Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
26
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Rock Patrick C. | Secretary, GC | 4 | $0 | $0 | 2015-08-14 |
| Hodges Mauri K | VP, Fin+Corp Sys & Controller | 3 | $0 | $0 | 2015-08-14 |
| DUNTON ALAN W | Director | 6 | $0 | $0 | 2015-08-14 |
| Richard John P | Director | 8 | $31.2K | $0 | 2015-08-14 |
| HILL STEPHEN A | President, CEO | 8 | $177.2K | $0 | 2015-08-14 |
| DESOUZA ERROL B | Director | 5 | $0 | $0 | 2015-08-14 |
| BLIXT CHARLES A | Director | 6 | $0 | $0 | 2015-08-14 |
| BROWN JULIA R | Director | 7 | $30.5K | $0 | 2015-08-14 |
| Toler Steven M. | VP, Clin Pharm Sciences | 3 | $0 | $0 | 2014-10-17 |
| Musso Alan A | SVP, Fin+Admin, CFO & Treas | 4 | $0 | $0 | 2014-10-17 |
| Hosford David A. | VP, Clin Dev & Reg Affairs | 2 | $0 | $0 | 2014-01-23 |
| SANDELL SCOTT D | 10% Owner | 6 | $0 | $32.6K | 2013-12-05 |
| BARRETT M JAMES | Director, 10% Owner | 10 | $0 | $113.3K | 2013-12-05 |
| BARRIS PETER J | 10% Owner | 6 | $0 | $32.6K | 2013-12-05 |
| SKALETSKY MARK B | Member, Office of the Chairman | 2 | $0 | $0 | 2013-06-07 |
| Hicks Karen A | VP, Human Resources | 2 | $0 | $0 | 2013-01-17 |
| Zorn Peter A | SVP, Lgl Affrs, GC & Secretary | 2 | $0 | $0 | 2013-01-17 |
| Brennan Jeffrey P | SVP, Bus. and Comm. Dev. & CBO | 2 | $0 | $0 | 2013-01-17 |
| Bencherif Merouane | SVP, Preclinical Research | 4 | $0 | $0 | 2013-01-17 |
| KRAMLICH C RICHARD | 10% Owner | 2 | $0 | $0 | 2012-11-19 |
| LAMPERT MARK N | 10% Owner | 10 | $5.81M | $0 | 2012-11-16 |
| BVF INVESTMENTS LLC | Other | 2 | $2.38M | $0 | 2012-11-16 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 4 | $292.1K | $0 | 2012-11-08 |
| BURRILL STEVEN | Director | 3 | $0 | $0 | 2012-07-31 |
| SNYDERMAN RALPH | Director | 1 | $0 | $0 | 2012-06-07 |
| deBethizy J Donald | President and CEO | 3 | $0 | $0 | 2012-05-04 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Richard John P | Director | A Award deriv | 2015-08-14 | 2015-08-18 | 0 | — | $0 | 0 | SEC↗ |
| DESOUZA ERROL B | Director | A Award deriv | 2015-08-14 | 2015-08-18 | 0 | — | $0 | 0 | SEC↗ |
| DUNTON ALAN W | Director | A Award deriv | 2015-08-14 | 2015-08-18 | 0 | — | $0 | 0 | SEC↗ |
| Hodges Mauri K | Treasurer, CFO | A Award deriv | 2015-08-14 | 2015-08-18 | 0 | — | $0 | 0 | SEC↗ |
| BLIXT CHARLES A | Director | A Award deriv | 2015-08-14 | 2015-08-18 | 0 | — | $0 | 0 | SEC↗ |
| Rock Patrick C. | Secretary, GC | A Award deriv | 2015-08-14 | 2015-08-18 | 0 | — | $0 | 0 | SEC↗ |
| BROWN JULIA R | Director | A Award deriv | 2015-08-14 | 2015-08-18 | 0 | — | $0 | 0 | SEC↗ |
| HILL STEPHEN A | President, CEO | A Award deriv | 2015-08-14 | 2015-08-18 | 0 | — | $0 | 0 | SEC↗ |
| BLIXT CHARLES A | Director | A Award deriv | 2015-08-04 | 2015-08-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BROWN JULIA R | Director | A Award deriv | 2015-08-04 | 2015-08-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| DUNTON ALAN W | Director | A Award deriv | 2015-08-04 | 2015-08-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| DUNTON ALAN W | Director | A Award | 2014-12-11 | 2014-12-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2014-12-11 | 2014-12-12 | 10,000 | — | $0 | 15,333 | SEC↗ |
| BROWN JULIA R | Director | A Award | 2014-12-11 | 2014-12-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BLIXT CHARLES A | Director | A Award | 2014-12-11 | 2014-12-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Richard John P | Director | A Award | 2014-12-11 | 2014-12-12 | 10,000 | — | $0 | 15,333 | SEC↗ |
| Toler Steven M. | VP, Clin Pharm Sciences | A Award | 2014-10-17 | 2014-10-21 | 45,000 | — | $0 | 46,000 | SEC↗ |
| HILL STEPHEN A | President & CEO | A Award | 2014-10-17 | 2014-10-21 | 175,000 | — | $0 | 195,000 | SEC↗ |
| Rock Patrick C. | SVP, GC and Secretary | A Award | 2014-10-17 | 2014-10-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Musso Alan A | SVP, Fin+Admin, CFO & Treas | A Award | 2014-10-17 | 2014-10-21 | 55,000 | — | $0 | 57,799 | SEC↗ |
| BLIXT CHARLES A | Director | A Award deriv | 2014-06-12 | 2014-06-13 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BROWN JULIA R | Director | A Award deriv | 2014-06-12 | 2014-06-13 | 12,500 | — | $0 | 12,500 | SEC↗ |
| DESOUZA ERROL B | Director | A Award deriv | 2014-06-12 | 2014-06-13 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Richard John P | Director | A Award deriv | 2014-06-12 | 2014-06-13 | 17,500 | — | $0 | 17,500 | SEC↗ |
| DUNTON ALAN W | Director | A Award deriv | 2014-06-12 | 2014-06-13 | 12,500 | — | $0 | 12,500 | SEC↗ |
| HILL STEPHEN A | President & CEO | A Award deriv | 2014-01-23 | 2014-01-24 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Musso Alan A | SVP, Fin+Admin, CFO & Treas | A Award deriv | 2014-01-23 | 2014-01-24 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Hosford David A. | VP, Clin Dev & Reg Affairs | A Award deriv | 2014-01-23 | 2014-01-24 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Rock Patrick C. | SVP, GC and Secretary | A Award deriv | 2014-01-23 | 2014-01-24 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Toler Steven M. | VP, Clin Pharm Sciences | A Award deriv | 2014-01-23 | 2014-01-24 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Richard John P | Director | A Award deriv | 2014-01-08 | 2014-01-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Richard John P | Director | A Award deriv | 2014-01-08 | 2014-01-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BARRETT M JAMES | 10% Owner | S Sale | 2013-12-05 | 2013-12-05 | 1,000 | $5.13 | $5.1K | 0 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | S Sale | 2013-12-05 | 2013-12-05 | 1,000 | $5.13 | $5.1K | 0 | SEC↗ |
| BARRIS PETER J | 10% Owner | S Sale | 2013-12-05 | 2013-12-05 | 1,000 | $5.13 | $5.1K | 0 | SEC↗ |
| BARRETT M JAMES | 10% Owner | M Exercise deriv | 2013-12-03 | 2013-12-05 | 7,500 | — | $0 | 0 | SEC↗ |
| BARRETT M JAMES | 10% Owner | M Exercise deriv | 2013-12-03 | 2013-12-05 | 7,500 | — | $0 | 0 | SEC↗ |
| BARRETT M JAMES | 10% Owner | M Exercise | 2013-12-03 | 2013-12-05 | 7,500 | $2.71 | $20.3K | 7,500 | SEC↗ |
| BARRETT M JAMES | 10% Owner | M Exercise | 2013-12-03 | 2013-12-05 | 7,500 | $4.16 | $31.2K | 15,000 | SEC↗ |
| BARRETT M JAMES | 10% Owner | S Sale | 2013-12-03 | 2013-12-05 | 15,000 | $5.38 | $80.7K | 0 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | S Sale | 2013-11-21 | 2013-11-22 | 5,333 | $5.16 | $27.5K | 1,000 | SEC↗ |
| BARRETT M JAMES | 10% Owner | S Sale | 2013-11-21 | 2013-11-22 | 5,333 | $5.16 | $27.5K | 1,000 | SEC↗ |
| BARRIS PETER J | 10% Owner | S Sale | 2013-11-21 | 2013-11-22 | 5,333 | $5.16 | $27.5K | 1,000 | SEC↗ |
| Rock Patrick C. | SVP, GC and Secretary | A Award deriv | 2013-09-30 | 2013-10-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BLIXT CHARLES A | Director | A Award deriv | 2013-06-07 | 2013-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BROWN JULIA R | Director | A Award deriv | 2013-06-07 | 2013-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| DESOUZA ERROL B | Director | A Award deriv | 2013-06-07 | 2013-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| DUNTON ALAN W | Director | A Award deriv | 2013-06-07 | 2013-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Richard John P | Director | A Award deriv | 2013-06-07 | 2013-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SKALETSKY MARK B | Director | A Award deriv | 2013-06-07 | 2013-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| BARRETT M JAMES | 10% Owner | X Exercise deriv | 2013-06-03 | 2013-06-04 | 1,000 | — | $0 | 0 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | X Exercise deriv | 2013-06-03 | 2013-06-04 | 1,000 | — | $0 | 0 | SEC↗ |
| BARRIS PETER J | 10% Owner | X Exercise deriv | 2013-06-03 | 2013-06-04 | 1,000 | — | $0 | 0 | SEC↗ |
| BARRETT M JAMES | 10% Owner | X Exercise | 2013-06-03 | 2013-06-04 | 1,000 | $0.08 | $80 | 6,333 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | X Exercise | 2013-06-03 | 2013-06-04 | 1,000 | $0.08 | $80 | 6,333 | SEC↗ |
| BARRIS PETER J | 10% Owner | X Exercise | 2013-06-03 | 2013-06-04 | 1,000 | $0.08 | $80 | 6,333 | SEC↗ |
| BROWN JULIA R | Director | P Buy | 2013-05-10 | 2013-05-13 | 6,000 | $5.09 | $30.5K | 6,000 | SEC↗ |
| HILL STEPHEN A | President and CEO | P Buy | 2013-03-11 | 2013-03-11 | 10,000 | $4.38 | $43.8K | 20,000 | SEC↗ |
| HILL STEPHEN A | President and CEO | P Buy | 2013-03-11 | 2013-03-11 | 10,000 | $4.38 | $43.8K | 20,000 | SEC↗ |
| HILL STEPHEN A | President and CEO | P Buy | 2013-03-08 | 2013-03-11 | 10,000 | $4.48 | $44.8K | 10,000 | SEC↗ |
| HILL STEPHEN A | President and CEO | P Buy | 2013-03-08 | 2013-03-11 | 10,000 | $4.48 | $44.8K | 10,000 | SEC↗ |
| Bencherif Merouane | SVP and Senior Scien Fellow | A Award deriv | 2013-01-17 | 2013-01-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Brennan Jeffrey P | SVP, Bus. and Comm. Dev. & C | A Award deriv | 2013-01-17 | 2013-01-18 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Hicks Karen A | VP, Human Resources | A Award deriv | 2013-01-17 | 2013-01-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Hodges Mauri K | VP, Fin+Corp Sys & Controlle | A Award deriv | 2013-01-17 | 2013-01-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Hosford David A. | VP, Clin Dev & Reg Affairs | A Award deriv | 2013-01-17 | 2013-01-18 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Musso Alan A | SVP, Fin+Admin, CFO & Treas | A Award deriv | 2013-01-17 | 2013-01-18 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Toler Steven M. | VP, Clin Pharm Sciences | A Award deriv | 2013-01-17 | 2013-01-18 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Zorn Peter A | SVP, Lgl Affrs, GC & Secreta | A Award deriv | 2013-01-17 | 2013-01-18 | 65,000 | — | $0 | 65,000 | SEC↗ |
| HILL STEPHEN A | President and CEO | A Award deriv | 2012-12-03 | 2012-12-05 | 400,000 | — | $0 | 400,000 | SEC↗ |
| KRAMLICH C RICHARD | 10% Owner | X Exercise deriv | 2012-11-19 | 2012-11-20 | 3,333 | — | $0 | 0 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | X Exercise deriv | 2012-11-19 | 2012-11-20 | 3,333 | — | $0 | 0 | SEC↗ |
| BARRIS PETER J | 10% Owner | X Exercise deriv | 2012-11-19 | 2012-11-20 | 3,333 | — | $0 | 0 | SEC↗ |
| KRAMLICH C RICHARD | 10% Owner | X Exercise | 2012-11-19 | 2012-11-20 | 3,333 | $0.08 | $267 | 5,333 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | X Exercise | 2012-11-19 | 2012-11-20 | 3,333 | $0.08 | $267 | 5,333 | SEC↗ |
| BARRIS PETER J | 10% Owner | X Exercise | 2012-11-19 | 2012-11-20 | 3,333 | $0.08 | $267 | 5,333 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2012-11-16 | 2012-11-19 | 46,700 | $5.11 | $238.6K | 2,646,619 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2012-11-16 | 2012-11-19 | 26,800 | $5.11 | $136.9K | 1,523,707 | SEC↗ |
| BVF INVESTMENTS LLC | Other | P Buy | 2012-11-16 | 2012-11-20 | 217,000 | $4.00 | $868.0K | 1,713,907 | SEC↗ |
| BVF INVESTMENTS LLC | Other | P Buy | 2012-11-16 | 2012-11-20 | 378,000 | $4.00 | $1.51M | 2,977,919 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2012-11-14 | 2012-11-19 | 444,649 | $4.00 | $1.78M | 1,496,907 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2012-11-14 | 2012-11-19 | 772,063 | $4.00 | $3.09M | 2,599,919 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | P Buy | 2012-11-08 | 2012-11-09 | 31,929 | $4.01 | $128.0K | 1,827,856 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | P Buy | 2012-11-08 | 2012-11-09 | 17,400 | $4.01 | $69.8K | 1,052,258 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | P Buy | 2012-11-07 | 2012-11-09 | 8,800 | $4.08 | $35.9K | 1,034,858 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | P Buy | 2012-11-07 | 2012-11-09 | 14,300 | $4.08 | $58.3K | 1,795,927 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2012-11-02 | 2012-11-02 | 36,100 | $4.05 | $146.2K | 1,781,627 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2012-11-02 | 2012-11-02 | 21,500 | $4.05 | $87.1K | 1,026,058 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2012-11-01 | 2012-11-02 | 23,400 | $4.05 | $94.8K | 1,004,558 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2012-11-01 | 2012-11-02 | 6,700 | $4.05 | $27.1K | 1,745,527 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2012-10-31 | 2012-11-02 | 46,700 | $4.06 | $189.6K | 1,738,827 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2012-10-31 | 2012-11-02 | 5,300 | $4.06 | $21.5K | 981,158 | SEC↗ |
| BURRILL STEVEN | Director | M Exercise deriv | 2012-07-31 | 2012-08-01 | 4,333 | — | $0 | 0 | SEC↗ |
| BURRILL STEVEN | Director | M Exercise | 2012-07-31 | 2012-08-01 | 4,333 | $0.08 | $347 | 4,333 | SEC↗ |
| SKALETSKY MARK B | Member, Office of the Chairm | A Award deriv | 2012-06-11 | 2012-06-13 | 57,500 | — | $0 | 57,500 | SEC↗ |
| Richard John P | Director | P Buy | 2012-06-08 | 2012-06-11 | 7,500 | $4.16 | $31.2K | 7,500 | SEC↗ |
| BLIXT CHARLES A | Director | A Award deriv | 2012-06-07 | 2012-06-08 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BROWN JULIA R | Director | A Award deriv | 2012-06-07 | 2012-06-08 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BURRILL STEVEN | Director | A Award deriv | 2012-06-07 | 2012-06-08 | 7,500 | — | $0 | 7,500 | SEC↗ |
| DESOUZA ERROL B | Director | A Award deriv | 2012-06-07 | 2012-06-08 | 7,500 | — | $0 | 7,500 | SEC↗ |
| DUNTON ALAN W | Director | A Award deriv | 2012-06-07 | 2012-06-08 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Richard John P | Director | A Award deriv | 2012-06-07 | 2012-06-08 | 7,500 | — | $0 | 7,500 | SEC↗ |
| SNYDERMAN RALPH | Director | A Award deriv | 2012-06-07 | 2012-06-08 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BARRETT M JAMES | Director, 10% Owner | A Award deriv | 2012-06-07 | 2012-06-11 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Bencherif Merouane | SVP, Preclinical Research | M Exercise deriv | 2012-05-18 | 2012-05-22 | 15,938 | — | $0 | 7,970 | SEC↗ |
| Bencherif Merouane | SVP, Preclinical Research | M Exercise | 2012-05-18 | 2012-05-22 | 15,938 | $2.93 | $46.7K | 15,938 | SEC↗ |
| Hodges Mauri K | VP Fin+Corp Sys and Controll | A Award deriv | 2012-05-04 | 2012-05-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Hicks Karen A | VP Human Resources | A Award deriv | 2012-05-04 | 2012-05-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Bencherif Merouane | SVP, Preclinical Research | A Award deriv | 2012-05-04 | 2012-05-08 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Brennan Jeffrey P | SVP - Bus. & Commercial Dev. | A Award deriv | 2012-05-04 | 2012-05-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Musso Alan A | SVP, CFO & Treasurer | A Award deriv | 2012-05-04 | 2012-05-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| deBethizy J Donald | President and CEO | A Award deriv | 2012-05-04 | 2012-05-08 | 135,000 | — | $0 | 135,000 | SEC↗ |
| Zorn Peter A | SVP, Lgl Affrs, GC & Secreta | A Award deriv | 2012-05-04 | 2012-05-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| deBethizy J Donald | President and CEO | M Exercise deriv | 2012-02-14 | 2012-02-16 | 798 | — | $0 | 0 | SEC↗ |
| deBethizy J Donald | President and CEO | M Exercise | 2012-02-14 | 2012-02-16 | 798 | $5.10 | $4.1K | 798 | SEC↗ |